BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pediatric Endocrine Society
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230913T120000
DTEND;TZID=America/New_York:20230913T130000
DTSTAMP:20231024T183859Z
CREATED:20230906T191129Z
LAST-MODIFIED:20231024T183859Z
UID:22892-1694606400-1694610000@pedsendo.org
SUMMARY:SIG State of the Art Webinar: Obesity
DESCRIPTION:September 13: State of the Art – Obesity \nTitle: Treating (Understanding) Complicated Obesity \nSpeaker: Gitanjali Srivastava\, MD\, FACP\, FAAP\, ABOM\, Vanderbilt University School of Medicine \nDescription: Join us to review novel therapeutics and treatment options for pediatric obesity and associated complications.
URL:https://pedsendo.org/event/sig-state-of-the-art-webinar-obesity/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230914T180000
DTEND;TZID=America/New_York:20230914T190000
DTSTAMP:20230906T173016Z
CREATED:20230906T172734Z
LAST-MODIFIED:20230906T173016Z
UID:22881-1694714400-1694718000@pedsendo.org
SUMMARY:Industry Sponsored Symposia - Achondroplasia a Multidisciplinary Conversation on Comprehensive Care
DESCRIPTION:Title: Achondroplasia a Multidisciplinary Conversation on Comprehensive Care \nDate: Thursday\, September 14 from 6:00 – 7:00pm EST \nSummary of Session:\nAchondroplasia (Ach)\, the most common skeletal dysplasia with disproportionate short stature\, is characterized by a number of medical\, functional\, and psychosocial challenges across the lifespan of an individual. Up until recently\, the treatment of the developmental complications of Ach involved only symptomatic management\, surgical intervention\, and lifelong follow-up care. An improved understanding of the molecular pathways involved in Ach has resulted in the development of new and emerging targeted therapies for this condition. These novel agents aim to restore bone growth and prevent many of the medical conditions associated with Ach. In this virtual live symposium\, an expert panel will address the complications associated with Ach\, current care recommendations\, strategies for coordination of care with specialists\, and new and emerging therapies for Ach.\n \nSpeakers: \n\nAndrew Dauber\, MD\, MMSc\, Chief of Endocrinology\, Children’s National Hospital\, Washington\, DC\nNadia Merchant\, MD\, Assistant Professor of Pediatrics\, Division of Endocrinology and Diabetes\, Children’s National Hospital\, Washington\, DC\nWilliam G. Mackenzie\, MD\, FRCS(c)\, FAAOS\, Chairman\, Department of Orthopedic Surgery\, Nemours Children’s Health\, Wilmington\, DE\n\n\n\nSponsored by BioMarin Pharmaceutical Inc.
URL:https://pedsendo.org/event/industry-sponsored-symposia-achondroplasia-a-multidisciplinary-conversation-on-comprehensive-care/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230925T160000
DTEND;TZID=America/New_York:20230925T170000
DTSTAMP:20231024T190500Z
CREATED:20230906T181121Z
LAST-MODIFIED:20231024T190500Z
UID:22889-1695657600-1695661200@pedsendo.org
SUMMARY:SEED Program: Rickets? Acquired vs inherited?
DESCRIPTION:Speaker:\nNadia Merchant\, MD\,\nAssistant Professor of Pediatrics\nPediatric Endocrinologist and Geneticist \nDescription:\nRickets can vary from being asymptomatic to irritability\, growth retardation\, and sudden death. Nutritional-acquired rickets is the most common cause of rickets worldwide that we still see in the US. Let’s learn about preventing nutritional rickets! This presentation will review causes of acquired vs inherited rickets\, pathophysiology\, and importance of evaluating and treating promptly to avoid long term complications. \n  \nView Recording
URL:https://pedsendo.org/event/seed-program-rickets-acquired-vs-inherited/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230928T190000
DTEND;TZID=America/New_York:20230928T200000
DTSTAMP:20230906T173101Z
CREATED:20230906T172936Z
LAST-MODIFIED:20230906T173101Z
UID:22884-1695927600-1695931200@pedsendo.org
SUMMARY:Industry Sponsored Symposia – Early Identification and Effective Management of Hypercholesterolemia in Children
DESCRIPTION:Title: Early Identification and Effective Management of Hypercholesterolemia in Children \n\nDate: Thursday\, September 28 from 7:00 – 8:00 pm Eastern \nSession Description:\nThis interactive virtual symposium\, sponsored by Regeneron Medical Affairs\, with Don P. Wilson\, MD\, a renowned pediatric lipidologist\, will focus on diagnosing lipid disorders (including familial hypercholesterolemia) and managing treatment goals in children. \nSpeaker: Don P. Wilson\, MD\, FNLA\, Department of Pediatric Endocrinology and Diabetes\, Endowed Chair\, Pediatric Cardiovascular Health and Risk Prevention Program\, Cook Children’s Medical Center\, Fort Worth\, Texas \nModerator: Matt Ito\, PharmD\, Associate Director\, Medical Affairs\, Regeneron Pharmaceuticals\, Inc. \nLearning Objectives:\nAs a result of participating in this interactive virtual symposium\, learners should be able to: \n\nDiscuss the role of hypercholesterolemia and atherosclerosis in cardiovascular disease (CVD) beginning in childhood\nExplain why early identification and treatment of at-risk children can help prevent atherosclerosis and atherosclerosis-related events\, such as myocardial infarction and stroke during childhood and adulthood\nDescribe current recommendations and best clinical practices for cholesterol screening and setting treatment goals in children\n\n  \nSponsored by Regeneron Pharmaceuticals\, Inc.
URL:https://pedsendo.org/event/industry-sponsored-symposia-early-identification-and-effective-management-of-hypercholesterolemia-in-children/
END:VEVENT
END:VCALENDAR